NUBURU Enters Medical Device Market with Order from European Manufacturer
15 Maggio 2024 - 2:30PM
Business Wire
Secures Purchase Order for BlueScan Solution
from a European Medical Device Manufacturer
NUBURU, Inc. (“NUBURU” or the “Company”) (NYSE American:
BURU), a leading innovator in high-power and high-brightness
industrial blue laser technology, today announced it has received a
purchase order for its BlueScan solution from Blueacre Technology,
a medical device manufacturer based in Dundalk, Ireland. The BL
laser will be integrated by Blueacre with scan head optics to
produce a versatile welding system for the manufacture of a range
of precision medical devices.
The order is a natural extension of the Company’s market focus
in the electric vehicle industry, next-generation computers,
consumer electronics and communication (3C) device manufacturing,
and medical devices. The NUBURU blue laser addresses the need for a
non-contact, high-speed process with low-to-no defects for
manufacturing batteries and electric vehicles by replacing slower
methods like ultrasonic and resistance welding, which represent
multibillion-dollar equipment spent today due to their high cost of
operations. It can work with copper, aluminum, titanium, and
stainless steel, facilitate the manufacture of electric vehicle
batteries, and address the tens of thousands of welds in an
electric vehicle.
David Gillen, Managing Director and owner of Blueacre
Technology commented: “Blue wavelength light is absorbed better
by metals than infra-red sources. Blue, therefore, reduces the heat
input into the material, reducing the risk of heat damage to
critical medical components. We are excited to add blue lasers to
our range of equipment.”
Brian Knaley, CEO of NUBURU commented: “Our focus remains
on providing world-class solutions to our customers’ most
challenging processes. These solutions are critical when welding
disparate materials in a precision environment like medical device
manufacturing. Blueacre will prove to be a world class partner in
this important market segment of medical device manufacturing which
is indicatively worth $6 billion according to AMPOWER 2022.”
The purchase order for NUBURU's BlueScan solution by Blueacre
Technology follows a successful Phase II contract award by the
National Aeronautics and Space Administration ("NASA") through its
Small Business Innovation Research ("SBIR") to advance blue laser
power transmission technology as a unique solution to dramatically
reduce the size and weight of the equipment needed for Lunar and
Martian applications.
About NUBURU
Founded in 2015, NUBURU, Inc. (NYSEAM: BURU) is a developer and
manufacturer of industrial blue lasers that leverage fundamental
physics and their high-brightness, high-power design to produce
faster, higher quality welds and parts than current lasers can
provide in laser welding and additive manufacturing of copper,
gold, aluminum and other industrially important metals. NUBURU’s
industrial blue lasers produce minimal to defect-free welds that
are up to eight times faster than the traditional approaches — all
with the flexibility inherent to laser processing. For more
information, please visit www.nuburu.net.
About Blueacre Technology
Blueacre Technology was founded in 2005 to provide contract
manufacturing solutions to the Medical Device industry. Its
world-leading laser micromachining capability allow it to provide
its global customers with high quality micro-devices and
sub-assemblies in aa range of both metals and polymers. For more
information, please visit https://blueacretechnology.com
Forward-Looking Statements
This press release contains certain “forward-looking statements”
within the meaning of the United States Private Securities
Litigation Reform Act of 1995, Section 27A of the Securities Act of
1933, as amended, and Section 21E of the Securities Exchange Act of
1934, as amended, including relating to its partnership with GE
Additive. All statements other than statements of historical fact
contained in this press release may be forward-looking statements.
Some of these forward-looking statements can be identified by the
use of forward-looking words, including “may,” “should,” “expect,”
“intend,” “will,” “estimate,” “anticipate,” “believe,” “predict,”
“plan,” “seek,” “targets,” “projects,” “could,” “would,”
“continue,” “forecast” or the negatives of these terms or
variations of them or similar expressions. Forward-looking
statements in this press release include, among other things:
anticipated benefits associated with laser-based additive
manufacturing. All forward-looking statements are subject to risks,
uncertainties, and other factors which could cause actual results
to differ materially from those expressed or implied by such
forward-looking statements. All forward-looking statements are
based upon estimates, forecasts and assumptions that, while
considered reasonable by NUBURU and its management, are inherently
uncertain and many factors may cause the company’s actual results
to differ materially from current expectations which include, but
are not limited to: (1) the ability to continue to meet the
security exchange’s listing standards; (2) failure to achieve
expectations regarding its product development and pipeline; (3)
the inability to access sufficient capital to operate as
anticipated, whether from Lincoln Park Capital Fund, LLC or other
sources; (4) the inability to recognize the anticipated benefits of
the business combination, which may be affected by, among other
things, competition, the ability of the company to grow and manage
growth profitably, maintain relationships with customers and
suppliers and retain its management and key employees; (5) changes
in applicable laws or regulations; (6) the possibility that NUBURU
may be adversely affected by other economic, business and/or
competitive factors; (7) volatility in the financial system and
markets caused by geopolitical and economic factors; (8) failing to
realize benefits from the partnership with GE Additive; and (9)
other risks and uncertainties set forth in the sections entitled
“Risk Factors” and “Cautionary Note Regarding Forward-Looking
Statements” in NUBURU’s most recent periodic report on Form 10-K or
Form 10-Q and other documents filed with the Securities and
Exchange Commission from time to time. These filings identify and
address other important risks and uncertainties that could cause
actual events and results to differ materially from those contained
in the forward-looking statements. Nothing in this press release
should be regarded as a representation by any person that the
forward-looking statements set forth herein will be achieved or
that any of the contemplated results of such forward-looking
statements will be achieved. You should not place undue reliance on
forward-looking statements, which speak only as of the date they
are made. NUBURU does not give any assurance that it will achieve
its expected results. NUBURU assumes no obligation to update or
revise these forward-looking statements, whether as a result of new
information, future events or otherwise, except as otherwise
required by applicable law.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240515953413/en/
Investor Relations: David Kugelman Atlanta Capital
Partners dk@atlcp.com
Grafico Azioni Nuburu (AMEX:BURU)
Storico
Da Ott 2024 a Nov 2024
Grafico Azioni Nuburu (AMEX:BURU)
Storico
Da Nov 2023 a Nov 2024